The human herpes simplex keratitis viruses are one of the leading cause of ophthalmic morbidity globally including cytomegalovirus retinitis in AIDS. The market of herpes simplex keratitis treatment is anticipated to grow significantly in the forecast period as the disease outbreak can cause unilateral corneal blindness worldwide. For herpes simplex keratitis treatment market, the basic understanding of how the virus behaves is helpful for manufacturers to understand the efforts that must still be concentrated on making the best use of new antiviral agents and other modes for avoiding inappropriate treatment.
This report contains market size and forecasts of Herpes Simplex Keratitis Drug in Global, including the following market information:
Global Herpes Simplex Keratitis Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Herpes Simplex Keratitis Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Oral Drug Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Herpes Simplex Keratitis Drug include GlaxoSmithKline, Vectans Pharma, Blistex, Bausch Health, Aurobindo Pharma, Dr. Reddy’s Laboratories, Cipla, Jubilant Cadista and Mylan. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Herpes Simplex Keratitis Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Herpes Simplex Keratitis Drug Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Herpes Simplex Keratitis Drug Market Segment Percentages, by Type, 2021 (%)
Oral Drug
Topical Drug
Global Herpes Simplex Keratitis Drug Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Herpes Simplex Keratitis Drug Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Herpes Simplex Keratitis Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Herpes Simplex Keratitis Drug Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Herpes Simplex Keratitis Drug revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Herpes Simplex Keratitis Drug revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlaxoSmithKline
Vectans Pharma
Blistex
Bausch Health
Aurobindo Pharma
Dr. Reddy’s Laboratories
Cipla
Jubilant Cadista
Mylan